Editorial: towards extended acid suppression - the search continues-Reference-Cited by-同舟云学术

Editorial: towards extended acid suppression - the search continues

Published:2015-09-15 Issue:8 Volume:42 Page:1027-1029
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Scarpignato C.¹,Hunt R. H.²

Affiliation:

1. Clinical Pharmacology & Digestive Pathophysiology Unit; Department of Clinical & Experimental Medicine; University of Parma; Parma Italy

2. Division of Gastroenterology and Farncombe Family Digestive Health Research Institute; Department of Medicine; McMaster University; Hamilton ON Canada

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13384/fullpdf

Reference15 articles.

1. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy;Hunt;Aliment Pharmacol Ther,2005

2. Review article: acid-related disease-what are the unmet clinical needs?;Katz;Aliment Pharmacol Ther,2006

3. Treatment patterns and symptom control in patients with GERD: US community-based survey;Chey;Curr Med Res Opin,2009

4. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD;Howden;J Clin Gastroenterol,2009

5. Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials;Vakily;Curr Med Res Opin,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15

2. Editorial: pharmacokinetic and pharmacodynamic model for vonoprazan—a step forward to precision medicine;Alimentary Pharmacology & Therapeutics;2023-06-12

3. A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection;Alimentary Pharmacology & Therapeutics;2023-04-17

4. Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study;Gut and Liver;2022-11-01

5. Acid-Lowering Drugs for the Treatment of Gastro-esophageal Reflux Disease;Gastroesophageal Reflux in Children;2022